VIR - Vir Biotechnology - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VIR is currently covered by 3 analysts with an average price target of $14.77. This is a potential upside of $5.51 (59.5%) from yesterday's end of day stock price of $9.26.

Vir Biotechnology's activity chart (see below) currently has 127 price targets and 96 ratings on display. The stock rating distribution of VIR is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50.97% with an average time for these price targets to be met of 150.08 days.

Highest price target for VIR is $21, Lowest price target is $15, average price target is $18.

Most recent stock forecast was given by JOSEPH STRINGER from NEEDHAM on 24-Feb-2026. First documented stock forecast 05-Nov-2019.

Currently out of the existing stock ratings of VIR, 7 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 11-Mar-2021

$18

$8.74 (94.38%)

$14

18 days ago
(24-Feb-2026)

0/18 (0%)

$10.57 (142.26%)

Buy Since 21-Sep-2020

$15

$5.74 (61.99%)

$15

2 months 12 days ago
(30-Dec-2025)

1/9 (11.11%)

$9.16 (156.85%)

128

Buy Since 21-Jul-2023

$21

$11.74 (126.78%)

$28

10 months 26 days ago
(16-Apr-2025)

5/11 (45.45%)

$15.56 (286.03%)

82

Buy Since 08-Jan-2025

$20

$10.74 (115.98%)

$20

1 years 1 days ago
(13-Mar-2025)

2/5 (40%)

$13 (185.71%)

108

Hold Since 29-Jan-2024

$14

$4.74 (51.19%)

$13

1 years 2 months 6 days ago
(08-Jan-2025)

3/7 (42.86%)

$1.52 (12.18%)

21

Show more analysts

Please expand the browser size to see the chart

What is VIR (Vir Biotechnology) average time for price targets to be met?

On average it took 150.08 days on average for the stock forecasts to be realized with a an average price target met ratio 50.97

Which analyst has the current highest performing score on VIR (Vir Biotechnology) with a proven track record?

ANUPAM RAMA

Which analyst has the most public recommendations on VIR (Vir Biotechnology)?

Anupam Rama works at JPMORGAN and has 30 price targets and 16 ratings on VIR

Which analyst is the currently most bullish on VIR (Vir Biotechnology)?

Alan Carr with highest potential upside - $33.74

Which analyst is the currently most reserved on VIR (Vir Biotechnology)?

Eric Joseph with lowest potential downside - $4.74

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?